<DOC>
	<DOCNO>NCT02674386</DOCNO>
	<brief_summary>A4091064 multicenter , long-term observational study subject tanezumab interventional study ( regardless treatment group ) undergo total knee , hip shoulder replacement participation study . The study design total duration subject follow-up 24 week total joint replacement surgery . There two method data collection utilized study : interview site staff via telephone interactive web-response system ( paper subject access internet ) .</brief_summary>
	<brief_title>Long-term Observational Study Subjects From Tanezumab Studies Who Undergo Total Knee , Hip Shoulder Replacement</brief_title>
	<detailed_description>A4091064 long-term observational follow study subject tanezumab interventional study A4091056 , A4091057 A4091058 .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Personally sign date informed consent document . Randomized treat subcutaneous investigational product tanezumab study complete study withdrawn study . Actual plan total knee , hip shoulder replacement surgery tanezumab study . Willing able comply schedule visit study procedure . None .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>